BrightPath Biotherapeutics
4594.TTSE GROWTHPharmaceutical
Filed as BrightPath Biotherapeutics Co., Ltd (2022-06–2026-06)
In English · 26
Wed, Oct 7 · JST1 filing
15:515% STAKEBrightPath Biotherapeutics · PhillipCapital Japan Ltd. · 19.90%new 19.90%Thu, Feb 19 · JST1 filing
09:005% STAKEBrightPath Biotherapeutics · Phillip Securities Japan, Ltd. · 6.29% → 4.88%−1.41ppThu, Jan 29 · JST1 filing
09:385% STAKEBrightPath Biotherapeutics · Phillip Securities Japan, Ltd. · 7.29% → 6.29%−1.00ppWed, Jan 21 · JST1 filing
13:255% STAKEBrightPath Biotherapeutics · Phillip Securities Japan, Ltd. · 7.29%new 7.29%Tue, Jan 20 · JST1 filing
13:415% STAKEBrightPath Biotherapeutics · Phillip Securities Japan, Ltd. · 18.94% → 9.24%−9.70ppTue, Jan 6 · JST1 filing
09:525% STAKEBrightPath Biotherapeutics · Phillip Securities Japan, Ltd. · 19.80% → 18.70%−1.10ppWed, Dec 17 · JST2 filings
17:045% STAKEBrightPath Biotherapeutics · Phillip Securities Japan, Ltd · 24.32%new 24.32%17:035% STAKEBrightPath Biotherapeutics · Phillip Securities Japan, Ltd · 24.68%new 24.68%Fri, Jul 11 · JST1 filing
12:255% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 7.72% → 4.62%−3.10ppThu, Jul 10 · JST1 filing
09:515% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 10.45% → 7.72%−2.73ppFri, Jun 27 · JST1 filing
12:025% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 14.00% → 10.45%−3.55ppTue, Jun 24 · JST1 filing
11:215% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 14.88% → 14.00%−0.88ppTue, May 27 · JST1 filing
10:225% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 15.47% → 14.88%−0.59ppThu, May 8 · JST1 filing
13:265% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 16.27% → 15.47%−0.80ppThu, Apr 17 · JST1 filing
11:335% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 16.91% → 16.27%−0.64ppMon, Mar 31 · JST1 filing
14:355% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 17.67% → 16.91%−0.76ppThu, Feb 27 · JST1 filing
15:165% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 18.35% → 17.67%−0.68ppFri, Jan 31 · JST1 filing
10:385% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 19.06% → 18.35%−0.71ppTue, Dec 10 · JST1 filing
11:155% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 19.71% → 19.06%−0.65ppTue, Nov 26 · JST1 filing
10:345% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 20.13% → 19.71%−0.42ppFri, Oct 25 · JST1 filing
10:215% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 20.93% → 20.13%−0.80ppFri, Sep 27 · JST1 filing
10:205% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 21.62% → 20.93%−0.69ppMon, Aug 26 · JST1 filing
11:325% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 22.31% → 21.62%−0.69ppWed, Aug 14 · JST1 filing
10:555% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 23.14% → 22.31%−0.83ppFri, Jul 26 · JST1 filing
15:455% STAKEBrightPath Biotherapeutics · Macquarie Bank Limited · 5.71% → 1.84%−3.87ppThu, Jul 25 · JST1 filing
10:395% STAKEBrightPath Biotherapeutics · Evo Fund + 1 joint holder · 24.41% → 23.14%−1.27ppAll EDINET filings · 119
| Filed | Document | Source |
|---|---|---|
| 2026-09-18 | Securities registration | S100Z38I |
| 2026-06-25 | CEO/CFO certification | S100YJSJ |
| 2026-06-25 | Internal control report | S100YJST |
| 2026-06-25 | Annual report | S100YJ3C |
| 2026-02-19 | Large shareholding report | S100XIMC |
| 2026-01-29 | Large shareholding report | S100XGZJ |
| 2026-01-21 | Large shareholding report | S100XGMY |
| 2026-01-20 | Large shareholding report | S100XE6W |
| 2026-01-06 | Amended large shareholding reportAmends S100XCPG | S100XEAU |
| 2026-01-06 | Large shareholding report | S100XCPG |
| 2025-12-18 | Amended large shareholding reportAmends S100XB3T | S100XBC0 |
| 2025-12-18 | Amended large shareholding reportAmends S100XB2X | S100XBBX |
| 2025-12-17 | Large shareholding report | S100XB3T |
| 2025-12-17 | Large shareholding report | S100XB2X |
| 2025-11-21 | Securities registration | S100X61Y |
| 2025-11-14 | CEO/CFO certification | S100X1BE |
| 2025-11-14 | Half-year report | S100X388 |
| 2025-07-11 | Large shareholding reportRelated to S100U170 | S100WCFV |
| 2025-07-10 | Large shareholding reportRelated to S100U170 | S100WBWL |
| 2025-06-27 | Large shareholding reportRelated to S100U170 | S100W7IQ |
| 2025-06-24 | Large shareholding reportRelated to S100U170 | S100W3BW |
| 2025-06-20 | Material event report | S100W1IK |
| 2025-06-19 | CEO/CFO certification | S100VZIR |
| 2025-06-19 | Internal control report | S100VZIW |
| 2025-06-19 | Annual report | S100VZBU |
| 2025-05-27 | Large shareholding reportRelated to S100U170 | S100VTHP |
| 2025-05-23 | Amended large shareholding reportAmends S100VPJZ | S100VT5B |
| 2025-05-08 | Large shareholding reportRelated to S100U170 | S100VPJZ |
| 2025-04-17 | Large shareholding reportRelated to S100U170 | S100VMT9 |
| 2025-03-31 | Large shareholding reportRelated to S100U170 | S100VIZA |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 21 financial reports not structured yet.
Not structured yet
| 2021-12-31 | quarterly | original indexed | S100NFIU |
| 2021-09-30 | quarterly | original indexed | S100MV4Y |
| 2021-06-30 | quarterly | original indexed | S100M9Q6 |
| 2021-03-31 | annual | original indexed | S100LQ6N |
| 2020-12-31 | quarterly | original indexed | S100KSN5 |
| 2020-09-30 | quarterly | original indexed | S100K60N |
| 2020-06-30 | quarterly | original indexed | S100JJEA |
| 2020-03-31 | annual | original indexed | S100J2Q6 |
| 2019-12-31 | quarterly | original indexed | S100I145 |
| 2019-09-30 | quarterly | original indexed | S100HAOS |
| 2019-06-30 | quarterly | original indexed | S100GQWV |
| 2019-03-31 | annual | original indexed | S100G377 |
| 2018-12-31 | quarterly | original indexed | S100F7V6 |
| 2018-09-30 | quarterly | original indexed | S100EHRM |
| 2018-06-30 | quarterly | original indexed | S100DWZF |
| 2018-03-31 | annual | original indexed | S100D9WP |
| 2017-12-31 | quarterly | pending download | S100CDZF |
| 2017-09-30 | quarterly | pending download | S100BQ7D |
| 2017-06-30 | quarterly | pending download | S100B5X2 |
| 2017-03-31 | annual | pending download | S100ASA1 |
| 2016-12-31 | quarterly | pending download | S1009OAU |